By Cara Murez HealthDay Reporter>FRIDAY, June 2, 2023 -- Americans aren't living as long as people in dozens of other developed nations — and the problem is worse than previously thought, a new study reveals.…
What to Do When Tough-to-Treat Lymphoma Strikes During…
By Cara Murez HealthDay Reporter>FRIDAY, June 2, 2023 -- Not a lot is known about how physicians should handle cases in which a pregnant woman is diagnosed with relapsed/refractory lymphoma. A new study may provide…
1 in 6 Unvaccinated People Struggle With Symptoms…
By Cara Murez HealthDay Reporter>FRIDAY, June 2, 2023 -- People unvaccinated for COVID-19 have significant odds of lingering illness if they get the virus, with one in six still suffering symptoms two years later, new…
Gene Changes Made This Seasons Bird Flu More…
By Dennis Thompson HealthDay Reporter>FRIDAY, June 2, 2023 -- Genetic mutations caused this latest bird flu season to become more severe, increasing the risk it poses to humans and other mammals, a new study finds.…
No Need to Avoid Exercise After Prolapse Surgery,…
By Cara Murez HealthDay Reporter>FRIDAY, June 2, 2023 -- It may not be necessary for people who have prolapse surgery for pelvic floor disorders to wait to get started exercising again. A new study challenges…
Medicare Will Cover New Class of Alzheimers Drugs…
News Consumer News Medicare Will Cover New Class of Alzheimer's Drugs if Fully Approved by FDA, With Limits By Cara Murez HealthDay Reporter>FRIDAY, June 2, 2023 -- Medicare will soon cover a new class of…
Software Bias Misses Lung Problems in Black Men,…
By Cara Murez HealthDay Reporter>FRIDAY, June 2, 2023 – A common test for lung function may be missing lung problems in Black men, leading to under-diagnosis and insufficient care. A new study from the University…
Is a Liver Dialysis Device on the Horizon?
By Dennis Thompson HealthDay Reporter>FRIDAY, June 2, 2023 -- A new liver dialysis device might soon be able to save patients on the edge of death from liver failure, early clinical trial results show. The…
FDA Approves Pfizer RSV Vaccine for Older Adults
By Physician’s Briefing Staff HealthDay Reporter>THURSDAY, June 1, 2023 -- Older adults have a second vaccine option for respiratory syncytial virus (RSV) following the U.S. Food and Drug Administration approval of a Pfizer vaccine on…
FDA Approves Pfizers RSV Shot for Older Adults,…
By Cara Murez HealthDay Reporter>THURSDAY, June 1, 2023 -- Older adults may have a second vaccine option for RSV following the U.S. Food and Drug Administration's approval of a Pfizer vaccine on Wednesday. The other…